Northern Trust’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-4,066,015
| Closed | -$720M | – | 4354 |
|
|
2020
Q1 | $720M | Sell |
4,066,015
-33,423
| -0.8% | -$6.29M | 0.21% | 98 |
|
|
2019
Q4 | $784M | Buy |
4,099,438
+23,525
| +0.6% | +$4.24M | 0.18% | 112 |
|
|
2019
Q3 | $686M | Buy |
4,075,913
+102,776
| +3% | +$16.7M | 0.16% | 125 |
|
|
2019
Q2 | $665M | Sell |
3,973,137
-59,591
| -1% | -$8.25M | 0.16% | 128 |
|
|
2019
Q1 | $590M | Sell |
4,032,728
-7,909
| -0.2% | -$1.15M | 0.15% | 138 |
|
|
2018
Q4 | $540M | Sell |
4,040,637
-2,517
| -0.1% | -$413K | 0.15% | 132 |
|
|
2018
Q3 | $770M | Sell |
4,043,154
-120,402
| -3% | -$22.1M | 0.19% | 104 |
|
|
2018
Q2 | $694M | Buy |
4,163,556
+69,651
| +2% | +$11.2M | 0.18% | 112 |
|
|
2018
Q1 | $689M | Sell |
4,093,905
-82,560
| -2% | -$13.8M | 0.18% | 115 |
|
|
2017
Q4 | $683M | Sell |
4,176,465
-355,781
| -8% | -$63.8M | 0.17% | 116 |
|
|
2017
Q3 | $929M | Buy |
4,532,246
+39,302
| +0.9% | +$9.14M | 0.24% | 81 |
|
|
2017
Q2 | $1.09B | Buy |
4,492,944
+364,722
| +9% | +$85.7M | 0.31% | 58 |
|
|
2017
Q1 | $986M | Sell |
4,128,222
-240,941
| -6% | -$56.1M | 0.28% | 66 |
|
|
2016
Q4 | $918M | Sell |
4,369,163
-571,930
| -12% | -$118M | 0.28% | 65 |
|
|
2016
Q3 | $1.14B | Buy |
4,941,093
+142,888
| +3% | +$34.9M | 0.35% | 54 |
|
|
2016
Q2 | $1.11B | Buy |
4,798,205
+343,633
| +8% | +$79.2M | 0.36% | 53 |
|
|
2016
Q1 | $1.2B | Buy |
4,454,572
+17,321
| +0.4% | +$4.96M | 0.4% | 50 |
|
|
2015
Q4 | $1.39B | Sell |
4,437,251
-319,689
| -7% | -$95.2M | 0.46% | 42 |
|
|
2015
Q3 | $1.29B | Sell |
4,756,940
-55,479
| -1% | -$17M | 0.43% | 47 |
|
|
2015
Q2 | $1.46B | Buy |
4,812,419
+23,759
| +0.5% | +$7.09M | 0.44% | 43 |
|
|
2015
Q1 | $1.43B | Buy |
4,788,660
+1,412,534
| +42% | +$403M | 0.43% | 44 |
|
|
2014
Q4 | $869M | Buy |
3,376,126
+39,002
| +1% | +$9.75M | 0.26% | 81 |
|
|
2014
Q3 | $805M | Buy |
3,337,124
+806,405
| +32% | +$180M | 0.25% | 85 |
|
|
2014
Q2 | $564M | Buy |
2,530,719
+126,168
| +5% | +$26.1M | 0.18% | 125 |
|
|
2014
Q1 | $495M | Buy |
2,404,551
+70,802
| +3% | +$14M | 0.16% | 134 |
|
|
2013
Q4 | $392M | Buy |
2,333,749
+1,077,544
| +86% | +$168M | 0.13% | 157 |
|
|
2013
Q3 | $181M | Sell |
1,256,205
-498,466
| -28% | -$66.4M | 0.06% | 303 |
|
|
2013
Q2 | $221M | Buy |
+1,754,671
| New | +$199M | 0.08% | 241 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Northern Trust's AGN Position: Q2 2020 in Review
Northern Trust sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 4,066,015 shares — an estimated $720M sold.
Northern Trust first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $1.46B in Q2 2015. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Northern Trust reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Northern Trust sold 4,066,015 Allergan plc shares in Q2 2020, an estimated $720M.
- Northern Trust first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Northern Trust's Allergan plc position peaked at $1.46B in Q2 2015.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Northern Trust's 13F filing for Q2 2020, filed 14 Aug 2020.